Biopharmaceutical Company Implements Cegedim Dendrite SaaS Aggregate Spend Reporting Solution

Comprehensive Solution Automates Reporting of Life Sciences Marketing Expenses, Ensuring Compliance

• Press Release
• Source: Cegedim Dendrite
• On 1:25 pm EDT, Tuesday October 27, 2009

BEDMINSTER, N.J.--(BUSINESS WIRE)--Cegedim Dendrite today announced that its State Guardian™ Software-as-a-Service (SaaS) solution has been implemented by a leading biopharmaceutical company to facilitate compliance with complex state regulations regarding the reporting of marketing expenditures. Cegedim Dendrite is the leading provider of compliance technology solutions and services in the Life Sciences industry.

Related Quotes

Symbol	Price	Change
CGM.PA	54.97	+0.47

{"s" : "cgm.pa","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Several states have recently enacted regulations governing the value and reporting of prescription drug marketing to health care providers and more states are expected to follow suit in the near future. In addition, there is a pending federal legislation called the Physician Payments Sunshine Act, often referred to as “The Sunshine Act,” which would enact similar regulations on a federal level. Many Life Sciences companies experience tremendous administrative challenges in collecting data from disparate systems and populating the different report templates required by the states in which they do business.

Cegedim Dendrite has been offering State Guardian™ in both SaaS and license models since 2006. It integrates and aggregates marketing expense and spend data from a range of enterprise applications, and continually updates, via leading edge technology, to reflect current and future changes in state and federal regulations. The solution is being leveraged by different types of manufacturers within the Life Sciences industry, including pharmaceutical and medical device suppliers.

“What differentiates us is the expertise of our staff,” stated Bill Buzzeo, Cegedim Dendrite VP & GM, Compliance and OneKey Solutions. “The baseline interpretation of legislation is done in-house, as is the technology development and the application of that legislation to the State Guardian™ product. Other vendors outsource these critical components of an aggregate spend solution.”

Cegedim Dendrite has been providing comprehensive compliance solutions to a broad range of pharmaceutical clients for 20 years. Leveraging BuzzeoPDMA’s depth of knowledge in the regulatory compliance category, Cegedim Dendrite is recognized as Life Sciences regulatory compliance experts, with many of their professionals having served in key capacities for state and federal regulatory agencies.

“Life Sciences companies are turning to technology for assistance with complying with these new regulations,” said Buzzeo. “It’s the practical thing to do. It would be cost-prohibitive for in-house staff to track current and pending regulations, and to implement the necessary compliance solutions in a timely manner. And for this client, it made sense to go with SaaS because of the benefits of fixed monthly costs and having Cegedim Dendrite maintain and update their system, taking the burden off their IT people.”

State Guardian™ supports multiple currencies and provides the added value of multiple views into aggregate spending at the prescriber, product and event levels, enabling improved tracking. It integrates natively with Cegedim Dendrite’s Nucleus, the Life Sciences industry’s most comprehensive Customer Master Data Management service.

About Cegedim Dendrite:

Cegedim Dendrite is the life sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Life Sciences by design, the company’s innovative business solutions and global reach incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world’s top companies to stay ahead of market challenges. Cegedim Dendrite also provides sales, marketing and regulatory compliance solutions in more than 80 countries.

Cegedim Dendrite is part of the France-based Cegedim S.A. Group.

To learn more, please visit www.cegedimdendrite.com.

About Cegedim:

Founded in 1969, Cegedim (Paris:CGM - News) is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies.

The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of €849 million in 2008. To learn more, please visit our website: www.cegedim.com

Listed on NYSE Euronext Paris, compartment B – ISIN FR0000053506 – Reuters CGDM.PA – Bloomberg CGM.

Media Inquiries:
Cegedim Dendrite
Drew Bustos
Global Communications
Tel.: +1 (908) 443.2451
drew.bustos@cegedimdendrite.com
or
Cegedim Group
Aude Balleydier
Media Relations
Tel. : + 33 (0)1 49 09 68 81
aude.balleydier@cegedim.fr